METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3
Abstract Protein methyltransferases regulate diverse physiological and pathological processes through histone and non-histone substrate methylation. While the role of histone methyltransferases in tumorigenesis is well-established, the contribution of non-histone methyltransferases, particularly Met...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-01021-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849238137577930752 |
|---|---|
| author | Ping Zhan Yizhe Cheng Yingcan Wu Jing Lu Jing Wen Xiaoqin Chi Changhong Luo Yiwei Peng Xijun Chen Fuqiang Wang Zhenyu Yin Chengrong Xie |
| author_facet | Ping Zhan Yizhe Cheng Yingcan Wu Jing Lu Jing Wen Xiaoqin Chi Changhong Luo Yiwei Peng Xijun Chen Fuqiang Wang Zhenyu Yin Chengrong Xie |
| author_sort | Ping Zhan |
| collection | DOAJ |
| description | Abstract Protein methyltransferases regulate diverse physiological and pathological processes through histone and non-histone substrate methylation. While the role of histone methyltransferases in tumorigenesis is well-established, the contribution of non-histone methyltransferases, particularly Methyltransferase 21A (METTL21A), to hepatocellular carcinoma (HCC) progression remains poorly characterized. Here, we report that METTL21A is significantly upregulated in HCC tissues and associated with poor clinical prognosis. Transcriptional activation by CCCTC-binding factor (CTCF) was identified as a key driver of METTL21A overexpression. Functional studies demonstrated that METTL21A promotes HCC growth and metastasis in both in vitro and in vivo models. Mechanistically, METTL21A mediates methylation of Bcl-2-associated athanogene-3 (BAG3), thereby inhibiting its ubiquitination and subsequent degradation. We further identified Tripartite motif containing 21 (TRIM21) as the E3 ligase responsible for BAG3 ubiquitination and found that METTL21A disrupts the TRIM21-BAG3 interaction. Notably, we discovered that the natural compound sophoricoside (Sop) acts as a METTL21A inhibitor and exhibits potent anti-HCC activity. Our study not only elucidates the oncogenic role and molecular mechanism of METTL21A in HCC progression but also highlights its therapeutic potential as a novel drug target for HCC treatment. |
| format | Article |
| id | doaj-art-478079d39d6a44648908d6e348b52c4f |
| institution | Kabale University |
| issn | 2397-768X |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | npj Precision Oncology |
| spelling | doaj-art-478079d39d6a44648908d6e348b52c4f2025-08-20T04:01:44ZengNature Portfolionpj Precision Oncology2397-768X2025-07-019111810.1038/s41698-025-01021-5METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3Ping Zhan0Yizhe Cheng1Yingcan Wu2Jing Lu3Jing Wen4Xiaoqin Chi5Changhong Luo6Yiwei Peng7Xijun Chen8Fuqiang Wang9Zhenyu Yin10Chengrong Xie11Fujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityFujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityFujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityFujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of Hepatobiliary Surgery, Xiamen Key Laboratory of Liver Diseases, Xiamen Hospital of Traditional Chinese Medicine, Beijing University of Chinese MedicineFujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityFujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of Hepatobiliary Surgery, Xiamen Key Laboratory of Liver Diseases, Xiamen Hospital of Traditional Chinese Medicine, Beijing University of Chinese MedicineFujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityFujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityFujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityFujian Provincial Key Laboratory of Chronic Liver Disease and Hepatocellular Carcinoma, Xiamen Translational Medical Key Laboratory of Digestive System Tumor, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityAbstract Protein methyltransferases regulate diverse physiological and pathological processes through histone and non-histone substrate methylation. While the role of histone methyltransferases in tumorigenesis is well-established, the contribution of non-histone methyltransferases, particularly Methyltransferase 21A (METTL21A), to hepatocellular carcinoma (HCC) progression remains poorly characterized. Here, we report that METTL21A is significantly upregulated in HCC tissues and associated with poor clinical prognosis. Transcriptional activation by CCCTC-binding factor (CTCF) was identified as a key driver of METTL21A overexpression. Functional studies demonstrated that METTL21A promotes HCC growth and metastasis in both in vitro and in vivo models. Mechanistically, METTL21A mediates methylation of Bcl-2-associated athanogene-3 (BAG3), thereby inhibiting its ubiquitination and subsequent degradation. We further identified Tripartite motif containing 21 (TRIM21) as the E3 ligase responsible for BAG3 ubiquitination and found that METTL21A disrupts the TRIM21-BAG3 interaction. Notably, we discovered that the natural compound sophoricoside (Sop) acts as a METTL21A inhibitor and exhibits potent anti-HCC activity. Our study not only elucidates the oncogenic role and molecular mechanism of METTL21A in HCC progression but also highlights its therapeutic potential as a novel drug target for HCC treatment.https://doi.org/10.1038/s41698-025-01021-5 |
| spellingShingle | Ping Zhan Yizhe Cheng Yingcan Wu Jing Lu Jing Wen Xiaoqin Chi Changhong Luo Yiwei Peng Xijun Chen Fuqiang Wang Zhenyu Yin Chengrong Xie METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3 npj Precision Oncology |
| title | METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3 |
| title_full | METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3 |
| title_fullStr | METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3 |
| title_full_unstemmed | METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3 |
| title_short | METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3 |
| title_sort | mettl21a promotes hepatocellular carcinoma progression via methylating and stabilizing bag3 |
| url | https://doi.org/10.1038/s41698-025-01021-5 |
| work_keys_str_mv | AT pingzhan mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 AT yizhecheng mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 AT yingcanwu mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 AT jinglu mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 AT jingwen mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 AT xiaoqinchi mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 AT changhongluo mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 AT yiweipeng mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 AT xijunchen mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 AT fuqiangwang mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 AT zhenyuyin mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 AT chengrongxie mettl21apromoteshepatocellularcarcinomaprogressionviamethylatingandstabilizingbag3 |